Home General Biotechnology Drug Patent Expirations in August 2012

Drug Patent Expirations in August 2012

Drug Patent Expirations for August 2012

TradenameApplicantGeneric NamePatent NumberPatent Expiration
PHOTOFRINPinnacle Biolgsporfimer sodium5438071Aug 1, 2012
SINGULAIRMerckmontelukast sodium5565473*PEDAug 3, 2012
SUSTIVABristol Myers Squibbefavirenz5811423Aug 7, 2012
ATRIPLAGileadefavirenz; emtricitabine; tenofovir disoproxil fumarate5811423Aug 7, 2012
CARDIZEM CDValeant Intldiltiazem hydrochloride5439689Aug 8, 2012
CHLORAPREP ONE-STEP FREPPCarefusionchlorhexidine gluconate; isopropyl alcoholD396911Aug 11, 2012
EXELONNovartisrivastigmine4948807Aug 14, 2012
EXELONNovartisrivastigmine tartrate4948807Aug 14, 2012
VITRAVENE PRESERVATIVE FREENovartisfomivirsen sodium5595978Aug 15, 2012
VITRAVENE PRESERVATIVE FREENovartisfomivirsen sodium5442049Aug 15, 2012
ALOCRILAllergannedocromil sodiumRE38628Aug 22, 2012
ACUTECTCis Bio Intl Satechnetium tc-99m apcitide5443815Aug 22, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.